Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Tissue Regenix Group (TRX) Share Price

Price 44.50p on 06-03-2025 at 11:38:05
Change -0.50p -1.11%
Buy 45.00p
Sell 44.00p
Buy / Sell TRX Shares
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Sell 100.00 at 44.05p
Day's Volume: 36,048
Last Close: 45.00p
Open: 45.00p
ISIN: GB00BNTXR104
Day's Range 44.50p - 45.00p
52wk Range: 43.10p - 74.00p
Market Capitalisation: £32m
VWAP: 43.31993p
Shares in Issue: 71m

Sector: Medicine and Biotech

Listed In: FTSE AIM All-Share,

Tissue Regenix Group (TRX) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 100 44.05p Ordinary
 11:38:04 - 06-Mar-25
Buy* 1,422 45.00p SI Trade
 10:58:41 - 06-Mar-25
Buy* 90 45.00p SI Trade
 10:58:41 - 06-Mar-25
Sell* 4 44.00p SI Trade
 10:58:40 - 06-Mar-25
Buy* 4 45.00p SI Trade
 10:58:40 - 06-Mar-25
Sell* 649 44.00p SI Trade
 10:58:40 - 06-Mar-25
Sell* 360 44.00p SI Trade
 10:58:40 - 06-Mar-25
Buy* 222 45.00p SI Trade
 10:58:40 - 06-Mar-25
Buy* 3 45.00p SI Trade
 10:58:40 - 06-Mar-25
Sell* 6,933 44.00p Ordinary
 10:58:29 - 06-Mar-25
See more Tissue Regenix Group trades

Tissue Regenix Group (TRX) Share Price History

Time period:
to
Date Open High Low Close Volume
6th Mar 2025 (Thu) 45.00 45.00 44.50 45.00 36,048
5th Mar 2025 (Wed) 45.00 45.00 43.10 45.00 65,180
4th Mar 2025 (Tue) 45.00 45.00 45.00 45.00 22,886
3rd Mar 2025 (Mon) 45.00 45.00 45.00 45.00 55,542
28th Feb 2025 (Fri) 45.00 45.00 43.90 45.00 10,337
27th Feb 2025 (Thu) 45.00 45.00 45.00 45.00 16,747
26th Feb 2025 (Wed) 45.00 45.00 45.00 45.00 27,424
25th Feb 2025 (Tue) 45.00 45.00 45.00 45.00 25,322
24th Feb 2025 (Mon) 45.00 45.00 45.00 45.00 6,619
21st Feb 2025 (Fri) 44.50 45.00 44.50 45.00 70,780
20th Feb 2025 (Thu) 47.00 44.50 44.00 44.50 111,395
19th Feb 2025 (Wed) 52.10 49.00 46.30 47.00 157,879
18th Feb 2025 (Tue) 52.50 52.50 52.10 52.10 20,499
17th Feb 2025 (Mon) 53.50 53.50 52.50 52.50 31,604
14th Feb 2025 (Fri) 57.50 57.50 53.50 53.50 126,864
13th Feb 2025 (Thu) 58.50 58.50 57.50 57.50 64,099
12th Feb 2025 (Wed) 60.00 60.00 58.50 58.50 47,420
11th Feb 2025 (Tue) 59.00 59.00 59.00 59.00 6,040
10th Feb 2025 (Mon) 59.00 59.00 59.00 59.00 54,603
7th Feb 2025 (Fri) 59.00 59.00 59.00 59.00 14,998
6th Feb 2025 (Thu) 59.00 59.00 59.00 59.00 11,553
See more Tissue Regenix Group price history

Tissue Regenix Group (TRX) Regulatory News

Date Source Headline
5th Mar 2025 8:54 am RNS Form 8.5 (EPT/NON-RI)
4th Mar 2025 9:28 am RNS Form 8.5 (EPT/NON-RI)
3rd Mar 2025 9:21 am RNS Form 8.5 (EPT/NON-RI)
21st Feb 2025 8:56 am RNS Form 8.5 (EPT/NON-RI)
20th Feb 2025 1:46 pm RNS Form 8.3 - Tissue Regenix Group PLC
20th Feb 2025 9:00 am RNS Form 8.5 (EPT/NON-RI)
19th Feb 2025 9:26 am RNS Form 8.5 (EPT/NON-RI)
18th Feb 2025 10:07 am RNS Form 8.5- Tissue Regenix Group Plc
17th Feb 2025 9:38 am RNS Form 8.5 (EPT/NON-RI)
14th Feb 2025 2:16 pm RNS Form 8.3 - Tissue Regenix Group PLC
See more Tissue Regenix Group regulatory news

Tissue Regenix Group (TRX) Share News

IN BRIEF: Tissue Regenix eyes profit beat; plots German jv disposal

31st Jan 2025 21:30

Tissue Regenix Group PLC - Leeds, England-based regenerative medical devices company - Revenue increases 8% to USD28.4 million in the year ending December 31 from USD26.3 million a year prior. In addition, expects to report an adjusted earnings before interest, tax, depreciation and amortisation above expectations. Notes this will mark the second full year of profitability for Tissue Regenix and the fourth year of above-market growth. Read More

IN BRIEF: Tissue Regenix contacts firms as it considers possible sale

4th Nov 2024 18:21

Tissue Regenix Group PLC - Leeds, England-based regenerative medical devices company - In response to press reports, say that it is conducting a review of strategic options, which may include soliciting offers for Tissue Regenix. Accordingly, the firm has contacted a limited number of potential counterparties to assess whether they could put forward a proposal "that would deliver greater value to Tissue Regenix's shareholders than pursuing a standalone independent strategy". Says it has not received any indicative non-binding proposals to date, and says there can be no certainty any offer will be made. Read More

EARNINGS AND TRADING: Blackbird loss narrows; Futura Medical in profit

10th Sep 2024 21:21

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

UK earnings, trading statements calendar - next 7 days

3rd Sep 2024 11:31

Read More

IN BRIEF: Tissue Regenix eyes revenue and adjusted profit growth

16th Jul 2024 11:30

Tissue Regenix Group PLC - Leeds, England-based regenerative medical devices company - Says trading in the first half of 2024 was strong, as it expects revenue to have climbed 16% to USD16.4 million from USD14.1 million a year prior. "The BioRinse segment continued to deliver solid growth driven by increased efficiencies, while the commercial reorganisation of the dCELL segment continued to show benefits, demonstrating robust growth within the period," Tissue Regenix says. It will report its full half-year results on September 10. Read More

See more Tissue Regenix Group news
FTSE 100 Latest
Value8,674.95
Change-80.89

Login to your account

Forgot Password?

Not Registered